IL115771A - Apolipoprotein-B synthesis inhibitors their preparation and pharmaceutical compositions containing them - Google Patents

Apolipoprotein-B synthesis inhibitors their preparation and pharmaceutical compositions containing them

Info

Publication number: IL115771A
Authority: IL; Israel
Prior art keywords: apolipoprotein; preparation; pharmaceutical compositions; compositions containing; synthesis inhibitors
Prior art date: 1994-10-27

Application number

IL11577195A

Other languages

English (en)

Other versions

IL115771A0 (en

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-27

Filing date

1995-10-26

Publication date

2000-02-29

1995-05-31 Priority claimed from US08/455,304 external-priority patent/US5521186A/en

1995-10-26 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

1995-10-26 Priority to IL13199295A priority Critical patent/IL131992A/xx

1996-01-19 Publication of IL115771A0 publication Critical patent/IL115771A0/xx

2000-02-29 Publication of IL115771A publication Critical patent/IL115771A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Diabetes (AREA)
Hematology (AREA)
Obesity (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Steroid Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

IL11577195A 1994-10-27 1995-10-26 Apolipoprotein-B synthesis inhibitors their preparation and pharmaceutical compositions containing them IL115771A (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
IL13199295A IL131992A (en)	1994-10-27	1995-10-26	Derivatives of 1,3-dioxolane

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP94203120		1994-10-27
US08/455,304 US5521186A (en)	1994-10-27	1995-05-31	Apolipoprotein-β synthesis inhibitors

Publications (2)

Publication Number	Publication Date
IL115771A0 IL115771A0 (en)	1996-01-19
IL115771A true IL115771A (en)	2000-02-29

Family

ID=26136684

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11577195A IL115771A (en)	1994-10-27	1995-10-26	Apolipoprotein-B synthesis inhibitors their preparation and pharmaceutical compositions containing them

Country Status (30)

Country	Link
US (1)	US5929075A (sk)
EP (1)	EP0788496B1 (sk)
JP (1)	JP3025907B2 (sk)
KR (1)	KR100227231B1 (sk)
CN (1)	CN1068000C (sk)
AP (1)	AP779A (sk)
AT (1)	ATE198889T1 (sk)
AU (1)	AU697744C (sk)
BG (1)	BG63694B1 (sk)
BR (1)	BR9509436A (sk)
CA (1)	CA2203274C (sk)
CY (1)	CY2256B1 (sk)
CZ (1)	CZ286476B6 (sk)
DE (3)	DE122007000005I2 (sk)
DK (1)	DK0788496T3 (sk)
ES (1)	ES2155535T3 (sk)
FI (1)	FI119548B (sk)
GR (1)	GR3035519T3 (sk)
HR (1)	HRP950532B1 (sk)
HU (1)	HU219862B (sk)
IL (1)	IL115771A (sk)
LU (1)	LU91306I2 (sk)
NO (1)	NO311937B1 (sk)
NZ (1)	NZ295353A (sk)
OA (1)	OA10479A (sk)
PT (1)	PT788496E (sk)
RO (1)	RO118715B1 (sk)
SK (1)	SK281908B6 (sk)
TR (1)	TR199501295A2 (sk)
WO (1)	WO1996013499A1 (sk)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU746890B2 (en) *	1997-11-03	2002-05-02	Janssen Pharmaceutica N.V.	Compositions of lipid lowering agents
EE200000796A (et) *	1998-04-27	2002-06-17	Janssen Pharmaceutica N.V.	Ravimkuulike, selle valmistamismeetod ja farmatseutiline doseerimisvorm, ravimkuulikeste kasutaminefarmatseutilise doseerimisvormi valmistamiseks ning farmatseutiline pakend
CA2355822A1 (en) *	1998-12-22	2000-06-29	Janssen Pharmaceutica N.V.	S-oxide lipid lowering compounds
DE19945982A1 (de)	1999-09-24	2001-03-29	Knoll Ag	Geschwindigkeitsbestimmte Partikel
US20050132022A1 (en) *	2003-12-12	2005-06-16	International Business Machines Corporation	Computer system with LAN-based I/O
AU2005205933B2 (en) *	2004-01-21	2010-02-18	Elanco Animal Health Ireland Limited	Mitratapide oral solution
US7649002B2 (en)	2004-02-04	2010-01-19	Pfizer Inc	(3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) *	2004-03-10	2007-08-28	Pfizer, Inc.	Substituted heteroaryl- and phenylsulfamoyl compounds
CA2562015A1 (en) *	2004-04-09	2005-10-20	Janssen Pharmaceutica Nv	Intermittent dosing regimens of apob secretion/mtp inhibitors for overweith and obese subjects
US20050288340A1 (en) *	2004-06-29	2005-12-29	Pfizer Inc	Substituted heteroaryl- and phenylsulfamoyl compounds
PA8660701A1 (es)	2005-02-04	2006-09-22	Pfizer Prod Inc	Agonistas de pyy y sus usos
WO2006129193A2 (en) *	2005-05-27	2006-12-07	Pfizer Products Inc.	Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
JP2009503050A (ja) *	2005-08-04	2009-01-29	ファイザー・リミテッド	ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物
US7741317B2 (en)	2005-10-21	2010-06-22	Bristol-Myers Squibb Company	LXR modulators
US7888376B2 (en)	2005-11-23	2011-02-15	Bristol-Myers Squibb Company	Heterocyclic CETP inhibitors
DK1989196T3 (da) *	2006-02-23	2013-04-15	Pfizer Ltd	Piperidinoylpyrrolidiner som melanocortin-type 4-receptoragonister
US8383660B2 (en)	2006-03-10	2013-02-26	Pfizer Inc.	Dibenzyl amine compounds and derivatives
WO2008059335A1 (en)	2006-11-13	2008-05-22	Pfizer Products Inc.	Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof
WO2008070496A2 (en)	2006-12-01	2008-06-12	Bristol-Myers Squibb Company	N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8765979B2 (en)	2007-05-25	2014-07-01	Janssen Pharmaceutica	Synthesis of (2S-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester)
JP5530438B2 (ja) *	2008-08-06	2014-06-25	ファイザー・リミテッド	Ｍｃ４作動薬としてのジアゼピンおよびジアゾカン化合物
WO2011144653A1 (en) *	2010-05-19	2011-11-24	Sandoz Ag	Process for the preparation of chiral triazolones
CN112074505B (zh)	2018-03-08	2024-04-05	因赛特公司	作为PI3K-γ抑制剂的氨基吡嗪二醇化合物
US11046658B2 (en)	2018-07-02	2021-06-29	Incyte Corporation	Aminopyrazine derivatives as PI3K-γ inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4218458A (en) *	1978-06-23	1980-08-19	Janssen Pharmaceutica, N.V.	Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4313953A (en) *	1978-06-23	1982-02-02	Janssen Pharmaceutica, N.V.	Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4766125A (en) *	1981-06-23	1988-08-23	Janssen Pharmaceutica N.V.	N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
US4619931A (en) *	1983-02-28	1986-10-28	Janssen Pharmaceutica, N.V.	[[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) *	1985-12-03	1991-11-26	Alfonsus Guilielmus Knaeps	Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl\|-1,3-dioxolan-2-yl\|methyl\|-1h-imidazoles and 1h-1,2,4-triazoles
NZ223799A (en) *	1987-03-25	1989-12-21	Janssen Pharmaceutica Nv	Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
CA1331757C (en) *	1988-02-29	1994-08-30	Janssen Pharmaceutica Naamloze Vennootschap	5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
AU6359594A (en) *	1993-03-04	1994-09-26	Cytoven International N.V.	Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
US5521186A (en) *	1994-10-27	1996-05-28	Janssen Pharmaceutica N.V.	Apolipoprotein-β synthesis inhibitors

1995
- 1995-10-19 RO RO97-00812A patent/RO118715B1/ro unknown
- 1995-10-19 DE DE122007000005C patent/DE122007000005I2/de active Active
- 1995-10-19 NZ NZ295353A patent/NZ295353A/en not_active IP Right Cessation
- 1995-10-19 DE DE1995619995 patent/DE122007000005I1/de active Pending
- 1995-10-19 JP JP8514288A patent/JP3025907B2/ja not_active Expired - Fee Related
- 1995-10-19 WO PCT/EP1995/004111 patent/WO1996013499A1/en active IP Right Grant
- 1995-10-19 EP EP95937804A patent/EP0788496B1/en not_active Expired - Lifetime
- 1995-10-19 AT AT95937804T patent/ATE198889T1/de active
- 1995-10-19 CZ CZ19971198A patent/CZ286476B6/cs not_active IP Right Cessation
- 1995-10-19 SK SK507-97A patent/SK281908B6/sk not_active IP Right Cessation
- 1995-10-19 BR BR9509436A patent/BR9509436A/pt not_active IP Right Cessation
- 1995-10-19 HU HU9701956A patent/HU219862B/hu not_active IP Right Cessation
- 1995-10-19 KR KR1019970702662A patent/KR100227231B1/ko not_active IP Right Cessation
- 1995-10-19 DK DK95937804T patent/DK0788496T3/da active
- 1995-10-19 DE DE69519995T patent/DE69519995T2/de not_active Expired - Lifetime
- 1995-10-19 ES ES95937804T patent/ES2155535T3/es not_active Expired - Lifetime
- 1995-10-19 US US08/817,247 patent/US5929075A/en not_active Expired - Lifetime
- 1995-10-19 PT PT95937804T patent/PT788496E/pt unknown
- 1995-10-19 CA CA002203274A patent/CA2203274C/en not_active Expired - Fee Related
- 1995-10-19 AP APAP/P/1997/000968A patent/AP779A/en active
- 1995-10-19 CN CN95195885A patent/CN1068000C/zh not_active Expired - Fee Related
- 1995-10-19 AU AU38680/95A patent/AU697744C/en not_active Ceased
- 1995-10-20 TR TR95/01295A patent/TR199501295A2/xx unknown
- 1995-10-26 IL IL11577195A patent/IL115771A/xx not_active IP Right Cessation
- 1995-10-27 HR HR950532A patent/HRP950532B1/xx not_active IP Right Cessation
1997
- 1997-04-10 BG BG101402A patent/BG63694B1/bg unknown
- 1997-04-24 NO NO19971895A patent/NO311937B1/no not_active IP Right Cessation
- 1997-04-25 FI FI971784A patent/FI119548B/fi not_active IP Right Cessation
- 1997-04-25 OA OA60997A patent/OA10479A/en unknown
2001
- 2001-03-05 GR GR20010400359T patent/GR3035519T3/el unknown
2002
- 2002-01-04 CY CY0200004A patent/CY2256B1/xx unknown
2007
- 2007-01-17 LU LU91306C patent/LU91306I2/fr unknown

Also Published As

Publication number	Publication date
EP0788496A1 (en)	1997-08-13
EP0788496B1 (en)	2001-01-24
NO971895D0 (no)	1997-04-24
DE69519995T2 (de)	2001-08-23
CY2256B1 (en)	2003-07-04
CA2203274C (en)	2002-02-19
SK281908B6 (sk)	2001-09-11
CN1068000C (zh)	2001-07-04
NO971895L (no)	1997-04-24
FI119548B (fi)	2008-12-31
CA2203274A1 (en)	1996-05-09
ATE198889T1 (de)	2001-02-15
LU91306I2 (fr)	2007-03-19
DE122007000005I1 (de)	2007-04-26
NO311937B1 (no)	2002-02-18
US5929075A (en)	1999-07-27
WO1996013499A1 (en)	1996-05-09
HU219862B (hu)	2001-08-28
AU697744C (en)	2002-08-22
IL115771A0 (en)	1996-01-19
BG101402A (en)	1997-10-31
HRP950532B1 (en)	2001-06-30
CZ286476B6 (en)	2000-04-12
JP3025907B2 (ja)	2000-03-27
AP9700968A0 (en)	1997-04-30
DK0788496T3 (da)	2001-06-18
HUT77360A (hu)	1998-03-30
CN1161695A (zh)	1997-10-08
RO118715B1 (ro)	2003-09-30
NZ295353A (en)	1998-08-26
TR199501295A2 (tr)	1996-06-21
AU697744B2 (en)	1998-10-15
AP779A (en)	1999-11-03
BG63694B1 (bg)	2002-09-30
DE122007000005I2 (de)	2008-04-24
SK50797A3 (en)	1998-04-08
JPH09511759A (ja)	1997-11-25
KR100227231B1 (ko)	1999-11-01
FI971784A (fi)	1997-04-25
ES2155535T3 (es)	2001-05-16
GR3035519T3 (en)	2001-06-29
BR9509436A (pt)	1998-01-06
DE69519995D1 (en)	2001-03-01
MX9703074A (es)	1997-07-31
CZ119897A3 (cs)	1998-03-18
AU3868095A (en)	1996-05-23
PT788496E (pt)	2001-07-31
OA10479A (en)	2002-04-09
FI971784A0 (fi)	1997-04-25
HRP950532A2 (en)	1997-08-31

Publication	Publication Date	Title
IL115771A (en)	2000-02-29	Apolipoprotein-B synthesis inhibitors their preparation and pharmaceutical compositions containing them
IL116957A0 (en)	1996-05-14	Substituted heterocyclic compounds their preparation and pharmaceutical compositions containing them
IL117860A0 (en)	1996-08-04	Substituted 1-phenyl-3-pyrazolecarboxamides their preparation and pharmaceutical compositions containing them
IL119078A (en)	2003-11-23	Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
IL122618A0 (en)	1998-08-16	Substituted imidazolylacetonitrile compounds their preparation and pharmaceutical compositions containing them
IL116851A (en)	2000-06-01	3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL114622A0 (en)	1995-11-27	Heteroaryl-oxazolidinones and pharmaceutical compositions containing them
AP2001002270A0 (en)	2001-09-30	Metalloproteinaise inhibitors pharmaceutical compositions containing them and their pharmaceeutical uses and methods and intermediates useful for their preparation
IL114626A0 (en)	1995-11-27	6-membered nitrogen-containing heteroaryl-oxazolidinones their preparation and pharmaceutical compositions containing them
IL114578A0 (en)	1995-11-27	Amino purine-béta-D ribofuranuronamide derivatives their preparation pharmaceutical compositions containing them and their use
IL122293A0 (en)	1998-04-05	Substituted 4-phenylaminothiazoles their preparation and pharmaceutical compositions containing them
IL116486A0 (en)	1997-08-14	Novel piperidine derivatives processes for their preparation and pharmaceutical compositions containing them
IL117349A0 (en)	1996-07-23	N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
IL122717A0 (en)	1998-08-16	Compounds and pharmaceutical compositions containing them
IL119559A0 (en)	1997-02-18	Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL115905A0 (en)	1996-01-31	Sordarin derivatives their preparation and pharmaceutical compositions containing them
IL125710A0 (en)	1999-04-11	Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
IL117554A0 (en)	1996-07-23	Imidazoquinazolines their preparation and pharmaceutical compositions containing them
IL122705A (en)	2001-01-28	2-(4-Susbstituted)-benzylamino-2-methyl-propanamide derivatives their preparation and pharmaceutical compositions containing them
IL116101A0 (en)	1996-01-31	Benzamide its preparation and pharmaceutical compositions containing it
IL114623A0 (en)	1995-11-27	Substituted triazolylmethylphenylnaph-thyridones their preparation and pharmaceutical compositions containing them
IL118672A0 (en)	1996-10-16	Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
IL119371A0 (en)	1997-01-10	Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
ZA948689B (en)	1995-07-04	New taxicin derivatives their preparation and pharmaceutical compositions containing them
IL118141A0 (en)	1996-09-12	Tetralines their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title
2000-06-29	FF	Patent granted
2000-10-31	KB	Patent renewed
2002-02-10	KB	Patent renewed
2006-01-15	KB	Patent renewed
2010-05-17	KB	Patent renewed
2014-06-30	MM9K	Patent not in force due to non-payment of renewal fees